Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and External Validation of a Nomogram for Predicting Hepatitis B Virus Reactivation in HBsAg-Negative/Anti-HBc-Positive Patients Undergoing Allogeneic Haematopoietic Stem Cell Transplantation: A Multicentre Prospective Study

NCT07644026 is registered in ClinicalTrials.gov with Xiao Hui Zhang as lead sponsor.

NCT NCT07644026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07644026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and External Validation of a Nomogram for Predicting Hepatitis B Virus Reactivation in HBsAg-Negative/Anti-HBc-Positive Patients Undergoing Allogeneic Haematopoietic Stem Cell Transplantation: A Multicentre Prospective Study
Lead sponsor
Xiao Hui Zhang
Phase
Observational
Overall status
Not yet recruiting
Start date
June 20, 2026
Completion date
June 30, 2029
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hbv reactivation, hsct